# Completeness Review: AIPathologySlideAnalyzer

- **Review date:** 2026-07-18
- **Assessment basis:** Static source and configuration inspection only. Dependencies were not installed, and no build, database migration, external integration, or runtime workflow was executed.

## Classification

**Prototype-demo**

## Verdict

This is a clinical/health prototype/demo. Its 68 source files and visible routes/pages demonstrate concepts, but they do not establish durable, integrated, tested execution of the AIPathology Slide Analyzer workflow.

## Why it is not complete

- 22 files are explicitly named as gap/backlog surfaces, so page and route counts overstate implemented product capability.
- 20 project-owned files contain direct provider/chat-completion markers; generic model calls are not a substitute for typed domain tools, grounded evidence, deterministic rules, or evaluations.
- 21 files contain mock, sample, placeholder, simulated, or random-data signals, leaving important outcomes disconnected from authoritative systems.
- No explicit schema or migration evidence was found for durable, versioned domain state.
- No recognizable project-owned automated tests were found for the primary workflow.
- No checked-in CI workflow was found to continuously verify builds, tests, migrations, and security checks.
- No environment example/template was found, leaving required configuration and secret boundaries undocumented.

## Needed features

1. Implement the Pathology Slide Analyzer care workflow with validated observations, decisions, ownership, follow-up, and clinician-visible uncertainty.
2. Connect authoritative EHR/FHIR, laboratory/imaging, device, pharmacy, scheduling, or payer systems appropriate to the workflow, with consent and failure handling.
3. Validate clinical accuracy, calibration, contraindications, missing-data behavior, bias, and escalation on versioned representative datasets.
4. Require clinician approval, least-privilege access, consent, immutable audit, retention controls, and a clearly documented non-diagnostic boundary.
5. Add DICOM/whole-slide ingestion, scanner and stain normalization, region annotation, specimen/case linkage, model/version provenance, pathologist review, and validated report export.
6. Add contract, integration, authorization, migration, failure-path, and end-to-end tests in CI, plus a documented nondestructive deployment/run path.

## Risks or launch blockers

- Incorrect or unreviewed output can cause patient harm.
- Health data requires strong privacy, access, retention, and audit controls.
- A weak JWT/session-secret fallback can make authentication forgeable when configuration is absent.
- The root launcher can terminate unrelated processes occupying configured ports.
- The root launcher seeds, creates, migrates, or otherwise mutates database state during startup.
- The root launcher installs dependencies at run time, reducing reproducibility and expanding supply-chain risk.

## Evidence inspected

- `backend/package.json` — inspected project-owned structure or implementation evidence.
- `backend/src/server.js` — inspected project-owned structure or implementation evidence.
- `backend/src/routes/gapFeat_auto_report_generate.js` — inspected project-owned structure or implementation evidence.
- `start.sh` — inspected project-owned structure or implementation evidence.
- `backend/src/database.js` — inspected project-owned structure or implementation evidence.
- `backend/package-lock.json` — inspected project-owned structure or implementation evidence.

## Recommended next action

Treat this as a prototype: prove one narrow clinical/health outcome end to end with real data, durable state, domain validation, and tests before expanding its feature catalog.

## Implementation progress

1. Implemented a non-diagnostic pathology-review workflow with case ownership, observations, uncertainty, discrepancy handling, follow-up ownership, and pathologist-approved report linkage.
2. Added DICOM, WSI, scanner, LIS, annotation, case, model-registry, and report provider contracts with consent, approval gating, request-bound idempotency, retry/dead-letter handling, reconciliation, and deletion receipts. Live clinical-system certification remains deployment work.
3. Added versioned protocol gates and fixtures for sensitivity, specificity, representative cohorts, failure modes, false negatives, and out-of-distribution escalation.
4. Added signed tenant/role context, independent qualified pathologist approval, append-only audit, bounded retention, scoped export/erasure, and an explicit autonomous-diagnosis prohibition.
5. Added checksummed DICOM/WSI identity, scanner/stain versions, calibration, annotations, specimen/case linkage, intended-use/model provenance, uncertainty regions, discrepancy disposition, and final report approval requirements.
6. Added contract/authorization/migration/failure/workflow tests, CI, blank secret templates, a non-destructive launcher, and clinical deploy/rollback/recovery/monitoring documentation; generated gaps are no longer mounted.
